Literature DB >> 30620159

Percutaneous resection of metastatic renal cell carcinoma.

Amir Toussi1, Deepak Agarwal1, Bradley Leibovich1, Aaron Potretzke1.   

Abstract

INTRODUCTION: Metastasis-directed therapy of small solitary foci of metastatic renal cell carcinoma has been associated with improved survival. Percutaneous resection of tumors in the upper tract urinary system has been widely used for treatment of localized urothelial carcinoma, however, its role in renal cell carcinoma has not been described. Herein, we present the first case of patient undergoing percutaneous resection of renal cell carcinoma in the contralateral renal pelvis.
MATERIALS AND METHODS: This is a case report describing the diagnosis, management and surgical approach to renal cell carcinoma recurrence in the contralateral renal pelvis.
RESULTS: Our patient was a 75-year-old male with a history of renal cell carcinoma status post radical nephrectomy who developed a solitary 2 cm recurrence in the contralateral renal pelvis, which was found after he presented with gross hematuria. He underwent successful percutaneous resection of this recurrence with final pathology showing clear cell renal cell carcinoma.
CONCLUSION: We present the first case of renal cell carcinoma recurrence in the contralateral renal pelvis treated with percutaneous resection. Copyright® by the International Brazilian Journal of Urology.

Entities:  

Mesh:

Year:  2019        PMID: 30620159      PMCID: PMC6786114          DOI: 10.1590/S1677-5538.IBJU.2018.0490

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


ARTICLE INFO

Available at: Int Braz J Urol. 2019; 45 (video #10): 640-640
  2 in total

1.  Curcumin Inhibits the Proliferation of Renal Cancer 786-O Cells through MTOR Signaling Pathway and Its Mechanism.

Authors:  Rui Gao; Yunfang Ma; Yali Wang; Haili Xu
Journal:  J Healthc Eng       Date:  2022-03-30       Impact factor: 2.682

2.  Metastasis of renal cell carcinoma to the ure-thra: a rare scenario.

Authors:  Sofia Frade Santos; Pedro Oliveira Santos; Delfim Doutel; Jose Venancio
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.